Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.1K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

359
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
359
Antigen Processing Pathways01:31

Antigen Processing Pathways

940
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
940
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta cell reactivity defines disease-relevant pancreatic CD8 T cells in type 1 diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Hypoxia-mediated epicardial signaling coordinates coronary angiogenesis and myocardial expansion during zebrafish ventricle maturation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Antigen-specific immunotherapy with a CD4<sup>+</sup> T cell neoepitope restrains CD8<sup>+</sup> T cell differentiation in murine pancreatic islet grafts.

Nature communications·2026
Same author

Quantitative V gene-targeted T cell receptor sequencing as a biomarker in type 1 diabetes.

JCI insight·2025
Same author

Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice.

Diabetes·2025
Same author

Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells.

Diabetes·2025

Related Experiment Video

Updated: Jun 8, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.7K

Epitope Hierarchy in Type 1 Diabetes Pathogenesis.

Thomas Delong1, Maki Nakayama2,3,4

  • 1Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA Thomas.delong@cuanschutz.edu maki.nakayama@cuanschutz.edu.

Cold Spring Harbor Perspectives in Medicine
|November 5, 2024
PubMed
Summary

Type 1 diabetes (T1D) involves T cells attacking insulin-producing cells. Researchers identified key T-cell epitopes, including pre-proinsulin and hybrid insulin peptides (HIPs), crucial for understanding T1D and developing new treatments.

More Related Videos

Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

10.8K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.4K

Related Experiment Videos

Last Updated: Jun 8, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.7K
Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

10.8K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.4K

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Type 1 diabetes (T1D) is an autoimmune condition where T cells destroy pancreatic beta cells.
  • Understanding the specific targets of these autoreactive T cells is vital for disease pathogenesis research and therapeutic development.

Purpose of the Study:

  • To review and identify key T-cell epitopes involved in Type 1 diabetes.
  • To highlight the role of pre-proinsulin and hybrid insulin peptides (HIPs) as significant autoantigens in T1D.
  • To discuss novel neoepitopes and the challenge of distinguishing pathogenic epitopes from mimotopes.

Main Methods:

  • Literature review of T-cell epitopes in Type 1 diabetes.
  • Analysis of evidence implicating insulin B-chain and C-peptide epitopes.
  • Examination of novel epitope classes including HIPs, posttranslational modifications, splice variants, and defective ribosomal products.

Main Results:

  • Insulin B-chain and C-peptide epitopes are dominant targets for pathogenic CD4+ and CD8+ T cells in T1D islets.
  • Hybrid insulin peptides (HIPs) represent a newly identified class of T1D epitopes found in human and mouse islets.
  • Various sources contribute to neoepitopes, including modifications and ribosomal products, complicating epitope identification.

Conclusions:

  • Identifying specific, pathogenic T-cell epitopes in T1D is critical for understanding disease mechanisms.
  • Distinguishing disease-driving epitopes from nonpathogenic mimotopes remains a significant challenge.
  • Discovery of essential epitopes could pave the way for antigen-specific immunotherapies for Type 1 diabetes.